BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 34698329)

  • 1. A multifunctional nano-delivery system enhances the chemo-
    Zhao R; Ning X; Wang M; Yu A; Wang Y
    J Mater Chem B; 2021 Nov; 9(44):9174-9182. PubMed ID: 34698329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TPGS-Galactose-Modified Polydopamine Co-delivery Nanoparticles of Nitric Oxide Donor and Doxorubicin for Targeted Chemo-Photothermal Therapy against Drug-Resistant Hepatocellular Carcinoma.
    Du Z; Mao Y; Zhang P; Hu J; Fu J; You Q; Yin J
    ACS Appl Mater Interfaces; 2021 Aug; 13(30):35518-35532. PubMed ID: 34286569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Near-infrared light switching nitric oxide nanoemitter for triple-combination therapy of multidrug resistant cancer.
    Wei G; Yang G; Wei B; Wang Y; Zhou S
    Acta Biomater; 2019 Dec; 100():365-377. PubMed ID: 31586724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance.
    Zhong P; Chen X; Guo R; Chen X; Chen Z; Wei C; Li Y; Wang W; Zhou Y; Qin L
    Mol Pharm; 2020 Apr; 17(4):1114-1126. PubMed ID: 32176509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NIR-II light triggered nitric oxide release nanoplatform combined chemo-photothermal therapy for overcoming multidrug resistant cancer.
    Wang J; Wu C; Qin X; Huang Y; Zhang J; Chen T; Wang Y; Ding Y; Yao Y
    J Mater Chem B; 2021 Feb; 9(6):1698-1706. PubMed ID: 33495772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporally Controlled Photothermal/Photodynamic and Combined Therapy for Overcoming Multidrug Resistance of Cancer by Polydopamine Nanoclustered Micelles.
    Xing Y; Ding T; Wang Z; Wang L; Guan H; Tang J; Mo D; Zhang J
    ACS Appl Mater Interfaces; 2019 Apr; 11(15):13945-13953. PubMed ID: 30907570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance.
    Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z
    ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of Chemoresistance via Staged Liberation of Chemodrug and siRNA in Hierarchical Response to ROS Gradient.
    Dang J; Li Y; Yan J; Wu J; Cai K; Yin L; Zhou Z
    Adv Healthc Mater; 2024 Jun; 13(15):e2304130. PubMed ID: 38427696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin Encapsulated in TPGS-Modified 2D-Nanodisks Overcomes Multidrug Resistance.
    Jiang T; Zhang C; Sun W; Cao X; Choi G; Choy JH; Shi X; Guo R
    Chemistry; 2020 Feb; 26(11):2470-2477. PubMed ID: 31912555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
    Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
    Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chondroitin sulfate-based nanoparticles for enhanced chemo-photodynamic therapy overcoming multidrug resistance and lung metastasis of breast cancer.
    Shi X; Yang X; Liu M; Wang R; Qiu N; Liu Y; Yang H; Ji J; Zhai G
    Carbohydr Polym; 2021 Feb; 254():117459. PubMed ID: 33357918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bufalin-loaded vitamin E succinate-grafted-chitosan oligosaccharide/RGD conjugated TPGS mixed micelles demonstrated improved antitumor activity against drug-resistant colon cancer.
    Yuan Z; Yuan Y; Han L; Qiu Y; Huang X; Gao F; Fan G; Zhang Y; Tang X; He X; Xu K; Yin P
    Int J Nanomedicine; 2018; 13():7533-7548. PubMed ID: 30532537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial targeted doxorubicin derivatives delivered by ROS-responsive nanocarriers to breast tumor for overcoming of multidrug resistance.
    Zhong XC; Shi MH; Liu HN; Chen JJ; Wang TT; Lin MT; Zhang ZT; Zhou Y; Lu YY; Xu WH; Gao JQ; Xu DH; Han M; Chen YD
    Pharm Dev Technol; 2021 Jan; 26(1):21-29. PubMed ID: 33070673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Y
    Wang Y; Jiang Z; Yuan B; Tian Y; Xiang L; Li Y; Yang Y; Li J; Wu A
    Biomater Sci; 2019 Nov; 7(11):4748-4757. PubMed ID: 31508613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multifunctional nanoplatform for cancer chemo-photothermal synergistic therapy and overcoming multidrug resistance.
    Peng Y; Nie J; Cheng W; Liu G; Zhu D; Zhang L; Liang C; Mei L; Huang L; Zeng X
    Biomater Sci; 2018 May; 6(5):1084-1098. PubMed ID: 29512657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-Assembly Nanoparticles for Overcoming Multidrug Resistance and Imaging-Guided Chemo-Photothermal Synergistic Cancer Therapy.
    Gao H; Bai Y; Chen L; Fakhri GE; Wang M
    Int J Nanomedicine; 2020; 15():809-819. PubMed ID: 32103938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondria-Responsive Drug Release along with Heat Shock Mediated by Multifunctional Glycolipid Micelles for Precise Cancer Chemo-Phototherapy.
    Tan Y; Zhu Y; Wen L; Yang X; Liu X; Meng T; Dai S; Ping Y; Yuan H; Hu F
    Theranostics; 2019; 9(3):691-707. PubMed ID: 30809302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting delivery.
    Bao Y; Yin M; Hu X; Zhuang X; Sun Y; Guo Y; Tan S; Zhang Z
    J Control Release; 2016 Aug; 235():182-194. PubMed ID: 27264552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversion of Multidrug Resistance by Co-Encapsulation of Doxorubicin and Metformin in Poly(lactide-co-glycolide)-d-α-tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles.
    Shafiei-Irannejad V; Samadi N; Salehi R; Yousefi B; Rahimi M; Akbarzadeh A; Zarghami N
    Pharm Res; 2018 Apr; 35(6):119. PubMed ID: 29671072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming multidrug resistance by intracellular drug release and inhibiting p-glycoprotein efflux in breast cancer.
    Mao J; Qiu L; Ge L; Zhou J; Ji Q; Yang Y; Long M; Wang D; Teng L; Chen J
    Biomed Pharmacother; 2021 Feb; 134():111108. PubMed ID: 33341670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.